Datar Cancer Genetics Unveils Exacta AI: A Revolutionary AI-Driven Cancer Treatment Platform

Metropolis Healthcare Partners with Roche to Launch Self-Sampling HPV DNA Test for Cervical Cancer Screening in India

Union Budget 2025: Full Exemption from Basic Customs Duty (BCD) for 36 Lifesaving Drugs

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

Union Budget 2025-26: Key Healthcare Measures for Cancer Care and Access to Life-Saving Drugs

FDA Approves Roche’s PATHWAY HER2 Test for Identifying HER2-Ultralow Breast Cancer Patients Eligible for ENHERTU

Bristol Myers Squibb’s Breyanzi® Receives CHMP Recommendation for Relapsed or Refractory Follicular Lymphoma in the EU

NHS to Offer Groundbreaking Gene Therapy for Sickle Cell Disease

Quibim Secures $50M Series A to Advance AI-Powered Imaging for Precision Medicine

Apollo Hospitals Unveils Advanced Oncology Facility in Chennai

Beckman Coulter’s Alzheimer’s Blood Test Receives FDA Breakthrough Device Designation

ANGLE Announces Breakthrough Dual CTC-DNA and ctDNA Analysis with Illumina’s NGS Solution

Diatech Pharmacogenetics and Merck Expand Collaboration to Enhance RAS Biomarker Testing in MEA Region

DCG Unveils AI-Powered Video-Reporting for Personalized Chemotherapy Selection

FDA Approves Monthly Maintenance Dosing for LEQEMBI® in Alzheimer’s Treatment

Home
/
update
/
details

Siemens Healthineers and Indian Institute of Science (IISc) Inaugurate AI Precision Medicine Laboratory in India

NextEdge Admin

28 Jan 2024

2 min 39 sec

Siemens Healthineers and the Indian Institute of Science (IISc) have officially opened the Siemens Healthineers-Computational Data Sciences (CDS) Collaborative Laboratory for AI in Precision Medicine in Bangalore. The Chief Technology Officer of Siemens Healthineers, Peter Schardt, inaugurated the cutting-edge laboratory. This collaborative effort aims to develop open-source AI tools for automating the segmentation of pathological findings in neuroimaging data, specifically focusing on precise diagnosis of neurological diseases and analyzing their clinical impact on a population level.

The establishment of the laboratory is part of Siemens Healthineers’ Corporate Social Responsibility initiative, which includes the provision of six M.Tech fellowships for women to enhance female representation in artificial intelligence. Dr. Vaanathi Sundaresan from IISc’s Department of CDS will lead the program. The laboratory will closely collaborate with neurologists, radiologists, and Siemens Healthineers to integrate developed computational models into regular clinical workflows.

Peter Schardt emphasized that the collaboration with IISc reinforces their commitment to advancing precision medicine through AI, using state-of-the-art, data-driven deep-learning techniques. The goal is to develop smart solutions that can contribute to saving lives through precise diagnoses and evidence-based treatments.

Prof Govindan Rangarajan, Director of the Indian Institute of Science, highlighted the significance of this partnership, stating that the lab represents a crucial step forward in unlocking the potential of AI for precision medicine. The collaboration showcases how industry and academia can join forces to address complex challenges and accelerate the future of healthcare.

The Siemens Healthineers and IISc partnership is deemed a milestone in artificial intelligence research in India, with the shared objective of combating severe neurovascular diseases globally and pioneering breakthroughs in healthcare.